MicroRNA-373 induces expression of genes with complementary promoter sequences
By R. Place, Long‐Cheng Li, Deepa Pookot, E. Noonan, Rajvir Dahiya. Proceedings of the National Academy of Sciences of the United States of America, 2008
1,261 citations recorded by the source corpus.
Subfields: Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/926fb859ac895b11a7f4c4491eda502c0861df21
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
- S. Barik
- Jiuyong Li
- Murray J. Cairns
- Jagjit Singh
- M. Takeichi
- Wenxiang Meng
- Bing Liu
- Girish C. Shukla
In Molecular Biology
- S. Barik
- Jiuyong Li
- Murray J. Cairns
- Jagjit Singh
- M. Takeichi
- Wenxiang Meng
- Bing Liu
- Girish C. Shukla
Citations in the corpus
- Adherens junction: molecular architecture and regulation. (2009, positive): “Another miRNA, miR-373, was found to induce E-cadherin expression by recognizing a target site in the promoter of the gene for E-cadherin (Li et al. 2006; Place et al. 2008).”
- Many roads to maturity: microRNA biogenesis pathways and their regulation (2009, background): “The re-import of miRNAs into the nucleus is especially relevant because evidence is accumulating that miRNAs could regulate gene expression in the nucleus at the transcriptional leve”
- MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions. (2011, background): “Intriguingly, recent evidence showed that miRNAs may target the promoter regions as well (48) and have the potential to activate gene expression (95).”
- Identifying miRNAs, targets and functions (2012, background): “Mature miRNAs can alter the expression of genes by binding to the 50-UTR [71, 72].”
- MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions (2016, background): “The first miRNA identified as an activator of gene transcription (TGA) was human miR-373, which induced transcription of both E-cadherin (CDH1) and cold-shock domain-containing protein 2 (CSDC2) [81].”